Overview

Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the effect of continuous and intermittent administration of Genotonorm on stature in short prepubertal children with intra-uterine growth retardation
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer